A further supportive contribution came from IHC and in vitro data displaying respectively an increase of EMT tissue markers such as vimentin and FOXM1 in DAA-related HCCs and enhanced migration capabilities in specific DAA-treated HCC cell lines. This evidence concerns the gene FOXM1 and hepatocellular carcinoma.